Authors:
CHABOT GG
ARMAND JP
TERRET C
DEFORNI M
ABIGERGES D
WINOGRAD B
IGWEMEZIE L
SCHACTER L
KAUL S
ROPERS J
BONNAY M
Citation: Gg. Chabot et al., ETOPOSIDE BIOAVAILABILITY AFTER ORAL-ADMINISTRATION OF THE PRODRUG ETOPOSIDE PHOSPHATE IN CANCER-PATIENTS DURING A PHASE-I STUDY, Journal of clinical oncology, 14(7), 1996, pp. 2020-2030
Authors:
WIBAULT P
BENSMAINE MEA
DEFORNI M
ARMAND JP
BERNAL ET
GUILLOT T
RECONDO G
DOMENGE C
JANOT F
BOREL C
LUBOINSKI B
ESCHWEGE F
CVITKOVIC E
Citation: P. Wibault et al., INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL, Journal of clinical oncology, 14(4), 1996, pp. 1192-1200
Authors:
MARTY M
KLEISBAUER JP
FOURNEL P
VERGNENEGRE A
CARLES P
LORIAKANZA Y
SIMONETTA C
DEBRUIJN KM
LAURAINE P
DIDIER A
CUPISSOL D
BERGERAT JP
PUJAZON MC
HERON JF
DRENO B
TAYTARD A
GUERIN JC
CLAVIER J
ROBINET G
BLANCHON F
BALMES P
MUIR JF
PAILLOTIN D
POIRIER R
BONNETERRE J
MELLONI B
ROCHE H
DEPIERRE A
PLAGNE R
SOUQUET PJ
ARMAND JP
DEFORNI M
Citation: M. Marty et al., IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6, 1995, pp. 15-21
Authors:
DEFORNI M
CHABOT GG
ARMAND JP
GOUYETTE A
KLINKALAK M
RECONDO G
Citation: M. Deforni et al., PHASE-I AND PHARMACOLOGY STUDY OF FLAVONE ACETIC-ACID ADMINISTERED 2 OR 3 TIMES WEEKLY WITHOUT ALKALINIZATION, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 219-224
Authors:
LEMAIRE L
MALETMARTINO MC
MARTINO R
DEFORNI M
LASSERRE B
Citation: L. Lemaire et al., THE TRIS FORMULATION OF FLUOROURACIL IS MORE CARDIOTOXIC THAN THE SODIUM-SALT FORMULATIONS, Oncology Reports, 1(1), 1994, pp. 173-174
Authors:
CHATELUT E
ROSTAING L
GUALANO V
VISSAC T
DEFORNI M
TONTHAT H
SUC JM
HOUIN G
CANAL P
Citation: E. Chatelut et al., PHARMACOKINETICS OF CARBOPLATIN IN A PATIENT SUFFERING FROM ADVANCED OVARIAN-CARCINOMA WITH HEMODIALYSIS-DEPENDENT PENAL INSUFFICIENCY, Nephron, 66(2), 1994, pp. 157-161
Authors:
DEFORNI M
BUGAT R
CHABOT GG
CULINE S
EXTRA JM
GOUYETTE A
MADELAINE I
MARTY ME
MATHIEUBOUE A
Citation: M. Deforni et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, ADMINISTERED ON A WEEKLY SCHEDULE IN CANCER-PATIENTS, Cancer research, 54(16), 1994, pp. 4347-4354
Authors:
DEFORNI M
CHABOT GG
ARMAND JP
FONTANA X
RECONDO G
DOMENGE C
CARDE P
BARBU M
GOUYETTE A
Citation: M. Deforni et al., PHASE-I AND PHARMACOKINETIC STUDY OF BREQUINAR (DUP-785 NSC-368390) IN CANCER-PATIENTS, European journal of cancer, 29A(7), 1993, pp. 983-988
Authors:
MULLER C
CHATELUT E
GUALANO V
DEFORNI M
HUGUET F
ATTAL M
CANAL P
LAURENT G
Citation: C. Muller et al., CELLULAR PHARMACOKINETICS OF DOXORUBICIN IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - COMPARISON OF BOLUS ADMINISTRATION AND CONTINUOUS-INFUSION, Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 379-384
Authors:
CODY R
STEWART D
DEFORNI M
MOORE M
DALLAIRE B
AZARNIA N
GYVES J
Citation: R. Cody et al., MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED BREAST-CANCER, American journal of clinical oncology, 16(6), 1993, pp. 526-528
Authors:
ARMAND JP
CVITKOVIC E
RECONDO G
WIBAULT P
SCHWAAB G
DOMENGE C
TELLEZBERNAL E
GANDIA D
LUBOINSKI B
ESCHWEGE F
DEFORNI M
Citation: Jp. Armand et al., SALVAGE CHEMOTHERAPY IN RECURRENT HEAD AND NECK-CANCER - THE INSTITUT-GUSTAVE-ROUSSY EXPERIENCE, American journal of otolaryngology, 14(5), 1993, pp. 301-306
Authors:
NGUYEN T
DEFORNI M
ARMAND JP
GUEGUEN M
AVRIL MF
Citation: T. Nguyen et al., COMPLETE REMISSION OF A SQUAMOUS-CELL CAR CINOMA TREATED WITH THE ASSOCIATION OF INTERFERON-ALPHA 2A AND ISOTRETINOIN AFTER FAILURE OF CONVENTIONAL THERAPIES, Annales de dermatologie et de venereologie, 120(11), 1993, pp. 827-829
Authors:
BACHAUD JM
DAVID JM
SHUBINSKI RE
PERINEAU D
BOUSSIN G
SERRANO E
DEFORNI M
PESSEY JJ
DALYSCHVEITZER NJ
Citation: Jm. Bachaud et al., PREDICTIVE FACTORS OF A COMPLETE RESPONSE TO AND ADVERSE-EFFECTS OF ACDDP-5FU COMBINATION AS PRIMARY THERAPY FOR HEAD AND NECK SQUAMOUS CARCINOMAS, Journal of Laryngology and Otology, 107(10), 1993, pp. 924-930
Authors:
DEFORNI M
GUALANO V
CANAL P
MARTEL P
IZARSOUM F
CHEVREAU C
SOULIE P
ROCHE H
BUGAT R
Citation: M. Deforni et al., CONTINUOUS-INFUSION OF 5-FLUOROURACIL BY DOUBLE ROUTE (INTRAVENOUS AND INTRAPERITONEAL) WITH MODULATION BY FOLINIC ACID - CLINICAL AND PHARMACOKINETIC, PHASE-I STUDY IN PATIENTS WITH INTRAABDOMINAL MALIGNANCIES, Bulletin du cancer, 80(5), 1993, pp. 408-417
Authors:
DEFORNI M
BONEU A
OTAL P
MARTEL P
SHUBINSKI R
BUGAT R
LUCOT H
Citation: M. Deforni et al., ANATOMIC CHANGES IN THE ABDOMINAL-CAVITY DURING INTRAPERITONEAL CHEMOTHERAPY - PROSPECTIVE-STUDY USING SCINTIGRAPHIC PERITONEOGRAPHY, Bulletin du cancer, 80(4), 1993, pp. 345-350